APA

Engelholm L. H., Melander M. C., Hald A., Persson M., Madsen D. H., Jürgensen H. J., Johansson K., Nielsen C., Nørregaard K. S., Ingvarsen S. Z., Kjaer A., Trovik C. S., Laerum O. D., Bugge T. H., Eide J. & Behrendt N. (20160523). Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180. : The Journal of pathology.

Chicago

Engelholm Lars H, Melander Maria C, Hald Andreas, Persson Morten, Madsen Daniel H, Jürgensen Henrik J, Johansson Kristina, Nielsen Christoffer, Nørregaard Kirstine S, Ingvarsen Signe Z, Kjaer Andreas, Trovik Clement S, Laerum Ole D, Bugge Thomas H, Eide Johan and Behrendt Niels. 20160523. Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180. : The Journal of pathology.

Harvard

Engelholm L. H., Melander M. C., Hald A., Persson M., Madsen D. H., Jürgensen H. J., Johansson K., Nielsen C., Nørregaard K. S., Ingvarsen S. Z., Kjaer A., Trovik C. S., Laerum O. D., Bugge T. H., Eide J. and Behrendt N. (20160523). Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180. : The Journal of pathology.

MLA

Engelholm Lars H, Melander Maria C, Hald Andreas, Persson Morten, Madsen Daniel H, Jürgensen Henrik J, Johansson Kristina, Nielsen Christoffer, Nørregaard Kirstine S, Ingvarsen Signe Z, Kjaer Andreas, Trovik Clement S, Laerum Ole D, Bugge Thomas H, Eide Johan and Behrendt Niels. Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180. : The Journal of pathology. 20160523.